{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:41:23Z","timestamp":1790012483247,"version":"4.0.1"},"reference-count":59,"publisher":"Oxford University Press (OUP)","issue":"5","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"name":"MSA Coalition"},{"name":"LABEX BRAIN","award":["ANR-10-LABX-43"],"award-info":[{"award-number":["ANR-10-LABX-43"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5,1]]},"DOI":"10.1093\/brain\/awx044","type":"journal-article","created":{"date-parts":[[2017,2,15]],"date-time":"2017-02-15T08:56:48Z","timestamp":1487149008000},"page":"1420-1436","source":"Crossref","is-referenced-by-count":102,"title":["Insulin resistance and exendin-4 treatment for multiple system atrophy"],"prefix":"10.1093","volume":"140","author":[{"given":"Fares","family":"Bassil","sequence":"first","affiliation":[{"name":"Univ. de Bordeaux, Institut des Maladies Neurod\u00e9g\u00e9n\u00e9ratives, UMR 5293, 33000 Bordeaux, France"},{"name":"CNRS, Institut des Maladies Neurod\u00e9g\u00e9n\u00e9ratives, UMR 5293, 33000 Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-H\u00e9l\u00e8ne","family":"Canron","sequence":"additional","affiliation":[{"name":"Univ. de Bordeaux, Institut des Maladies Neurod\u00e9g\u00e9n\u00e9ratives, UMR 5293, 33000 Bordeaux, France"},{"name":"CNRS, Institut des Maladies Neurod\u00e9g\u00e9n\u00e9ratives, UMR 5293, 33000 Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Vital","sequence":"additional","affiliation":[{"name":"Univ. de Bordeaux, Institut des Maladies Neurod\u00e9g\u00e9n\u00e9ratives, UMR 5293, 33000 Bordeaux, France"},{"name":"CNRS, Institut des Maladies Neurod\u00e9g\u00e9n\u00e9ratives, UMR 5293, 33000 Bordeaux, France"},{"name":"Service de Pathologie, CHU de Bordeaux, 33000 Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwan","family":"Bezard","sequence":"additional","affiliation":[{"name":"Univ. de Bordeaux, Institut des Maladies Neurod\u00e9g\u00e9n\u00e9ratives, UMR 5293, 33000 Bordeaux, France"},{"name":"CNRS, Institut des Maladies Neurod\u00e9g\u00e9n\u00e9ratives, UMR 5293, 33000 Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazhou","family":"Li","sequence":"additional","affiliation":[{"name":"Translational Gerontology Branch, Intramural Research Program, National Institute on Aging, Baltimore, MD 21224, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel H","family":"Greig","sequence":"additional","affiliation":[{"name":"Translational Gerontology Branch, Intramural Research Program, National Institute on Aging, Baltimore, MD 21224, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Gulyani","sequence":"additional","affiliation":[{"name":"Laboratory of Neurosciences, National Institute on Aging, Baltimore, MD 21224, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Kapogiannis","sequence":"additional","affiliation":[{"name":"Laboratory of Neurosciences, National Institute on Aging, Baltimore, MD 21224, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Olivier","family":"Fernagut","sequence":"additional","affiliation":[{"name":"Univ. de Bordeaux, Institut des Maladies Neurod\u00e9g\u00e9n\u00e9ratives, UMR 5293, 33000 Bordeaux, France"},{"name":"CNRS, Institut des Maladies Neurod\u00e9g\u00e9n\u00e9ratives, UMR 5293, 33000 Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wassilios G","family":"Meissner","sequence":"additional","affiliation":[{"name":"Univ. de Bordeaux, Institut des Maladies Neurod\u00e9g\u00e9n\u00e9ratives, UMR 5293, 33000 Bordeaux, France"},{"name":"CNRS, Institut des Maladies Neurod\u00e9g\u00e9n\u00e9ratives, UMR 5293, 33000 Bordeaux, France"},{"name":"Centre de R\u00e9f\u00e9rence Maladie Rare AMS, H\u00f4pital Pellegrin, CHU de Bordeaux, F-33076 Bordeaux, France"},{"name":"Service de Neurologie, H\u00f4pital Pellegrin, CHU de Bordeaux, 33000 Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,3,14]]},"reference":[{"key":"key\n\t\t\t\t20180226040618_awx044-B1","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1172\/JCI68295","article-title":"Exenatide and the treatment of patients with Parkinson\u2019s disease","volume":"123","author":"Aviles-Olmos","year":"2013","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20180226040618_awx044-B2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3233\/JPD-140364","article-title":"Motor and cognitive advantages persist 12 months after exenatide exposure in Parkinson\u2019s disease","volume":"4","author":"Aviles-Olmos","year":"2014","journal-title":"J Parkinsons Dis"},{"key":"key\n\t\t\t\t20180226040618_awx044-B3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2014.02.005","article-title":"Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: targets for disease modification?","volume":"118","author":"Bassil","year":"2014","journal-title":"Prog Neurobiol"},{"key":"key\n\t\t\t\t20180226040618_awx044-B4","doi-asserted-by":"crossref","first-page":"9593","DOI":"10.1073\/pnas.1609291113","article-title":"Reducing C-terminal truncation mitigates synucleinopathy and neurodegeneration in a transgenic model of multiple system atrophy","volume":"113","author":"Bassil","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20180226040618_awx044-B5","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1172\/JCI57256","article-title":"An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer\u2019s disease- associated Abeta oligomers","volume":"122","author":"Bomfim","year":"2012","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20180226040618_awx044-B6","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0896-6273(93)90173-O","article-title":"Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice","volume":"10","author":"Carson","year":"1993","journal-title":"Neuron"},{"key":"key\n\t\t\t\t20180226040618_awx044-B7","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.nbd.2009.05.023","article-title":"Alterations in lysosomal and proteasomal markers in Parkinson\u2019s disease: relationship to alpha-synuclein inclusions","volume":"35","author":"Chu","year":"2009","journal-title":"Neurobiol Dis"},{"key":"key\n\t\t\t\t20180226040618_awx044-B8","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S1474-4422(15)00006-X","article-title":"Targeting alpha-synuclein for treatment of Parkinson\u2019s disease: mechanistic and therapeutic considerations","volume":"14","author":"Dehay","year":"2015","journal-title":"Lancet Neurol"},{"key":"key\n\t\t\t\t20180226040618_awx044-B9","doi-asserted-by":"crossref","first-page":"12535","DOI":"10.1523\/JNEUROSCI.1920-10.2010","article-title":"Pathogenic lysosomal depletion in Parkinson\u2019s disease","volume":"30","author":"Dehay","year":"2010","journal-title":"J Neurosci"},{"key":"key\n\t\t\t\t20180226040618_awx044-B10","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s40478-014-0150-6","article-title":"Altered lipid levels provide evidence for myelin dysfunction in multiple system atrophy","volume":"2","author":"Don","year":"2014","journal-title":"Acta Neuropathol Commun"},{"key":"key\n\t\t\t\t20180226040618_awx044-B11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00401-016-1572-y","article-title":"alpha-Synuclein-induced myelination deficit defines a novel interventional target for multiple system atrophy","volume":"132","author":"Ettle","year":"2016","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t20180226040618_awx044-B12","unstructured":"FDA. Estimating the safe starting dose in clinical trials for therapeutics in adult healthy volunteers, Center for Drug Evaluation and Research and Center for Biologics Evaluation and Research 2005. Available from: http:\/\/www.fda.gov\/downloads\/Drugs\/\u2026\/Guidances\/UCM078932.pdf"},{"key":"key\n\t\t\t\t20180226040618_awx044-B13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.nbd.2014.03.021","article-title":"Multiple system atrophy: a prototypical synucleinopathy for disease-modifying therapeutic strategies","volume":"67","author":"Fernagut","year":"2014","journal-title":"Neurobiol Dis"},{"key":"key\n\t\t\t\t20180226040618_awx044-B14","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/syn.20456","article-title":"Behavioral and histopathological consequences of paraquat intoxication in mice: effects of alpha-synuclein over-expression","volume":"61","author":"Fernagut","year":"2007","journal-title":"Synapse"},{"key":"key\n\t\t\t\t20180226040618_awx044-B15","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/syn.21719","article-title":"Age-related motor dysfunction and neuropathology in a transgenic mouse model of multiple system atrophy","volume":"68","author":"Fernagut","year":"2014","journal-title":"Synapse"},{"key":"key\n\t\t\t\t20180226040618_awx044-B16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neuroscience.2011.09.044","article-title":"Animal models of multiple system atrophy","volume":"211","author":"Fernagut","year":"2012","journal-title":"Neuroscience"},{"key":"key\n\t\t\t\t20180226040618_awx044-B17","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jalz.2014.06.008","article-title":"Identification of preclinical Alzheimer\u2019s disease by a profile of pathogenic proteins in neurally derived blood exosomes: a case-control study","volume":"11","author":"Fiandaca","year":"2015","journal-title":"Alzheimers Dement"},{"key":"key\n\t\t\t\t20180226040618_awx044-B18","doi-asserted-by":"crossref","first-page":"9434","DOI":"10.1523\/JNEUROSCI.3080-04.2004","article-title":"Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein","volume":"24","author":"Fleming","year":"2004","journal-title":"J Neurosci"},{"key":"key\n\t\t\t\t20180226040618_awx044-B19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.biocel.2015.03.006","article-title":"Alpha-synuclein overexpression negatively regulates insulin receptor substrate 1 by activating mTORC1\/S6K1 signaling","volume":"64","author":"Gao","year":"2015","journal-title":"Int J Biochem Cell Biol"},{"key":"key\n\t\t\t\t20180226040618_awx044-B20","doi-asserted-by":"crossref","first-page":"28","DOI":"10.12688\/f1000research.3-28.v2","article-title":"Astrocytes require insulin-like growth factor I to protect neurons against oxidative injury","volume":"3","author":"Genis","year":"2014","journal-title":"F1000Res"},{"key":"key\n\t\t\t\t20180226040618_awx044-B21","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","article-title":"Second consensus statement on the diagnosis of multiple system atrophy","volume":"71","author":"Gilman","year":"2008","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180226040618_awx044-B22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1212\/WNL.0000000000001702","article-title":"Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease","volume":"85","author":"Goetzl","year":"2015","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180226040618_awx044-B23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.biochi.2004.10.019","article-title":"Positive and negative regulation of insulin signaling through IRS-1 phosphorylation","volume":"87","author":"Gual","year":"2005","journal-title":"Biochimie"},{"key":"key\n\t\t\t\t20180226040618_awx044-B24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1742-2094-5-19","article-title":"Glucagon-like peptide 1 receptor stimulation reverses key deficits in distinct rodent models of Parkinson\u2019s disease","volume":"5","author":"Harkavyi","year":"2008","journal-title":"J Neuroinflammation"},{"key":"key\n\t\t\t\t20180226040618_awx044-B25","doi-asserted-by":"crossref","first-page":"e21594","DOI":"10.1371\/journal.pone.0021594","article-title":"Insulin promotes glycogen storage and cell proliferation in primary human astrocytes","volume":"6","author":"Heni","year":"2011","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180226040618_awx044-B26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1440-1789.2007.00855.x","article-title":"Glial cytoplasmic inclusions and tissue injury in multiple system atrophy: a quantitative study in white matter (olivopontocerebellar system) and gray matter (nigrostriatal system)","volume":"28","author":"Ishizawa","year":"2008","journal-title":"Neuropathology"},{"key":"key\n\t\t\t\t20180226040618_awx044-B27","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/1098-2396(20001215)38:4<450::AID-SYN10>3.0.CO;2-J","article-title":"Insulin-like growth factor-I and its receptor in the frontal cortex, hippocampus, and cerebellum of normal human and alzheimer disease brains","volume":"38","author":"Jafferali","year":"2000","journal-title":"Synapse"},{"key":"key\n\t\t\t\t20180226040618_awx044-B28","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/embo-reports\/kvf109","article-title":"Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes","volume":"3","author":"Kahle","year":"2002","journal-title":"EMBO Rep"},{"key":"key\n\t\t\t\t20180226040618_awx044-B29","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1096\/fj.14-262048","article-title":"Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural-derived blood exosomes of preclinical Alzheimer\u2019s disease","volume":"29","author":"Kapogiannis","year":"2015","journal-title":"FASEB J"},{"key":"key\n\t\t\t\t20180226040618_awx044-B30","doi-asserted-by":"crossref","first-page":"e55243","DOI":"10.1371\/journal.pone.0055243","article-title":"FAS-dependent cell death in alpha-synuclein transgenic oligodendrocyte models of multiple system atrophy","volume":"8","author":"Kragh","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180226040618_awx044-B31","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s10495-008-0309-3","article-title":"Cell death pathways in Parkinson\u2019s disease: proximal triggers, distal effectors, and final steps","volume":"14","author":"Levy","year":"2009","journal-title":"Apoptosis"},{"key":"key\n\t\t\t\t20180226040618_awx044-B32","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1073\/pnas.0806720106","article-title":"GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism","volume":"106","author":"Li","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20180226040618_awx044-B33","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/glia.20496","article-title":"IGF-1 stimulates de novo fatty acid biosynthesis by Schwann cells during myelination","volume":"55","author":"Liang","year":"2007","journal-title":"Glia"},{"key":"key\n\t\t\t\t20180226040618_awx044-B34","doi-asserted-by":"crossref","first-page":"5703","DOI":"10.1523\/JNEUROSCI.20-15-05703.2000","article-title":"Insulin-like growth factor-1 inhibits mature oligodendrocyte apoptosis during primary demyelination","volume":"20","author":"Mason","year":"2000","journal-title":"J Neurosci"},{"key":"key\n\t\t\t\t20180226040618_awx044-B35","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.neurobiolaging.2008.04.002","article-title":"Defects in IGF-1 receptor, insulin receptor and IRS-1\/2 in Alzheimer\u2019s disease indicate possible resistance to IGF-1 and insulin signalling","volume":"31","author":"Moloney","year":"2010","journal-title":"Neurobiol Aging"},{"key":"key\n\t\t\t\t20180226040618_awx044-B36","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.tcb.2013.07.007","article-title":"Oligodendroglia: metabolic supporters of axons","volume":"23","author":"Morrison","year":"2013","journal-title":"Trends Cell Biol"},{"key":"key\n\t\t\t\t20180226040618_awx044-B37","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/jnr.490300214","article-title":"Insulin-like growth factor I stimulates oligodendrocyte development and myelination in rat brain aggregate cultures","volume":"30","author":"Mozell","year":"1991","journal-title":"J Neurosci Res"},{"key":"key\n\t\t\t\t20180226040618_awx044-B38","doi-asserted-by":"crossref","first-page":"11167","DOI":"10.1074\/jbc.M114.629063","article-title":"Insulin and Insulin-like Growth Factor 1 (IGF-1) modulate cytoplasmic glucose and glycogen levels but not glucose transport across the membrane in astrocytes","volume":"290","author":"Muhic","year":"2015","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20180226040618_awx044-B39","first-page":"243","article-title":"Immunohistochemical localization of phosphoinositide 3-kinase in brains with multiple system atrophy","volume":"20","author":"Nakamura","year":"2001","journal-title":"Clin Neuropathol"},{"key":"key\n\t\t\t\t20180226040618_awx044-B40","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/00005072-199807000-00006","article-title":"Cyclin-dependent kinase 5 and mitogen-activated protein kinase in glial cytoplasmic inclusions in multiple system atrophy","volume":"57","author":"Nakamura","year":"1998","journal-title":"J Neuropathol Exp Neurol"},{"key":"key\n\t\t\t\t20180226040618_awx044-B41","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.parkreldis.2013.11.005","article-title":"Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson\u2019s disease, multiple system atrophy and progressive supranuclear palsy","volume":"20","author":"Numao","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"issue":"Pt 12","key":"key\n\t\t\t\t20180226040618_awx044-B42","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1093\/brain\/awh303","article-title":"The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations","volume":"127","author":"Ozawa","year":"2004","journal-title":"Brain"},{"issue":"Pt 2","key":"key\n\t\t\t\t20180226040618_awx044-B43","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/brain\/117.2.235","article-title":"The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology","volume":"117","author":"Papp","year":"1994","journal-title":"Brain"},{"key":"key\n\t\t\t\t20180226040618_awx044-B44","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1002\/mds.23320","article-title":"Multiple system atrophy is associated with changes in peripheral insulin-like growth factor system","volume":"25","author":"Pellecchia","year":"2010","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20180226040618_awx044-B45","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.nbd.2014.11.008","article-title":"Changes in total cell numbers of the basal ganglia in patients with multiple system atrophy\u2014a stereological study","volume":"74","author":"Salvesen","year":"2015","journal-title":"Neurobiol Dis"},{"key":"key\n\t\t\t\t20180226040618_awx044-B46","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0006-8993(96)00664-6","article-title":"Preproinsulin I and II mRNAs and insulin electron microscopic immunoreaction are present within the rat fetal nervous system","volume":"736","author":"Schechter","year":"1996","journal-title":"Brain Res"},{"key":"key\n\t\t\t\t20180226040618_awx044-B47","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1097\/00001756-199809140-00020","article-title":"Microglial activation in multiple system atrophy: a potential role for NF-kappaB\/rel proteins","volume":"9","author":"Schwarz","year":"1998","journal-title":"Neuroreport"},{"key":"key\n\t\t\t\t20180226040618_awx044-B48","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.2353\/ajpath.2007.070201","article-title":"p25alpha relocalizes in oligodendroglia from myelin to cytoplasmic inclusions in multiple system atrophy","volume":"171","author":"Song","year":"2007","journal-title":"Am J Pathol"},{"key":"key\n\t\t\t\t20180226040618_awx044-B49","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0002-9440(10)62307-3","article-title":"Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy","volume":"166","author":"Stefanova","year":"2005","journal-title":"Am J Pathol"},{"key":"key\n\t\t\t\t20180226040618_awx044-B50","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1002\/mds.21671","article-title":"Microglial activation mediates neurodegeneration related to oligodendroglial alpha-synucleinopathy: implications for multiple system atrophy","volume":"22","author":"Stefanova","year":"2007","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20180226040618_awx044-B51","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1172\/JCI59903","article-title":"Demonstrated brain insulin resistance in Alzheimer\u2019s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline","volume":"122","author":"Talbot","year":"2012","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20180226040618_awx044-B52","doi-asserted-by":"crossref","first-page":"6236","DOI":"10.1523\/JNEUROSCI.0567-10.2010","article-title":"Neurodegeneration in a transgenic mouse model of multiple system atrophy is associated with altered expression of oligodendroglial-derived neurotrophic factors","volume":"30","author":"Ubhi","year":"2010","journal-title":"J Neurosci"},{"key":"key\n\t\t\t\t20180226040618_awx044-B53","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/ana.21465","article-title":"Multiple system atrophy: a primary oligodendrogliopathy","volume":"64","author":"Wenning","year":"2008","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20180226040618_awx044-B54","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.neuint.2013.06.010","article-title":"Alpha-synuclein overexpression increases phospho-protein phosphatase 2A levels via formation of calmodulin\/Src complex","volume":"63","author":"Yang","year":"2013","journal-title":"Neurochem Int"},{"key":"key\n\t\t\t\t20180226040618_awx044-B55","doi-asserted-by":"crossref","first-page":"6190","DOI":"10.1073\/pnas.92.13.6190","article-title":"Insulin-like growth factor I treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis","volume":"92","author":"Yao","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20180226040618_awx044-B56","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00401-014-1328-5","article-title":"Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer\u2019s disease and tauopathies","volume":"128","author":"Yarchoan","year":"2014","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t20180226040618_awx044-B57","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/glia.20469","article-title":"Insulin-like growth factor type 1 receptor signaling in the cells of oligodendrocyte lineage is required for normal in vivo oligodendrocyte development and myelination","volume":"55","author":"Zeger","year":"2007","journal-title":"Glia"},{"key":"key\n\t\t\t\t20180226040618_awx044-B58","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0962-8924(01)02129-8","article-title":"Insulin resistance: a phosphorylation-based uncoupling of insulin signaling","volume":"11","author":"Zick","year":"2001","journal-title":"Trends Cell Biol"},{"key":"key\n\t\t\t\t20180226040618_awx044-B59","doi-asserted-by":"crossref","first-page":"pe4","DOI":"10.1126\/stke.2682005pe4","article-title":"Ser\/Thr phosphorylation of IRS proteins: a molecular basis for insulin resistance","volume":"2005","author":"Zick","year":"2005","journal-title":"Sci STKE"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/140\/5\/1420\/24175049\/awx044.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,24]],"date-time":"2022-07-24T04:54:15Z","timestamp":1658638455000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article\/140\/5\/1420\/3065511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,14]]},"references-count":59,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,3,14]]},"published-print":{"date-parts":[[2017,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awx044","relation":{},"ISSN":["0006-8950","1460-2156"],"issn-type":[{"value":"0006-8950","type":"print"},{"value":"1460-2156","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,5]]},"published":{"date-parts":[[2017,3,14]]}}}